Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Synairgen Supercharges R&D With $100m Financing

To Support COVID-19 Study Of Inhaled Beta-Interferon

Oct 15 2020

• By John Davis

Stock market chart,Stock market data on LED display concept. — • Source: Shutterstock

Related Content

Silence Therapeutics Continues Transformation, Improves US Visibility

Sep 08 2020

UK Biotech Defies Pandemic, On Course For Record Fundraising Year

Oct 12 2020

GSK’s Emma Walmsley Made A Dame In UK Honors

Oct 12 2020

Stockwatch: Some Failed Drugs Never Die, They Just Find New Investors

Oct 11 2020

Finance Watch: Four IPOs In One Week, And Legend Is Year’s Largest So Far

Jun 06 2020

Related Companies

Synairgen plc

Adaptimmune Therapeutics plc

Verona Pharma plc

Spur Therapeutics Limited

Silence Therapeutics plc

Additional Topics

Financing Coronavirus COVID-19 Commercial Research & Development StartUps and SMEs Infectious Diseases BioPharmaceutical

More from Financing

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.